Mutations of the Retinoblastoma Gene in Human Lymphoid Neoplasms

References

• Cossman J., Stetler-Stevenson M., Medeiros L. J., Raffeld M. Molecular genetics of lymphoproliferative processes. Important Adv. Oncol. 1990; 101–113
   PubMedGoogle Scholar
• Krolewski J. J., Dalla-Favera R. Molecular and genetic approaches in the diagnosis and classification of lymphoid malignancies. Hematol. Pathol. 1989; 3: 45–61
   PubMedGoogle Scholar
• Stanbridge E. J., Cavenee W. K. Oncogenes and the Molecular Origins of Cancer, R. A. Weinberg. Cold Spring Harbor Lab, Cold Spring Harbor, NY 1989; 281–306
   Google Scholar
• Knudsen A. G. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 1971; 68: 820–3
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. The Rb gene and the negative regulation of cell growth. Blood 1989; 2: 529–32
   Google Scholar
• Levine A. J., Momand J., Finlay C. A. The p53 tumor suppressor gene. Nature 1991; 351: 453–6
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–67
   PubMed Web of Science ®Google Scholar
• Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rappaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–6
   PubMed Web of Science ®Google Scholar
• Lee W. H., Bookstein R., Hong F., Young L. H., Shew J. Y., Lee E. Y. Human retinoblastoma susceptibility gene: Cloning, identification and sequence. Science 1987; 235: 1394–9
   PubMed Web of Science ®Google Scholar
• Fung Y., Murphree A. L., Ang A., Qian J., Hinrichs S. H., Benedict W. F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 241: 1657–61
   Web of Science ®Google Scholar
• Ludlow J. W., Shon J., Pipas J. M., Livingston D. M., De Caprio J. A. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 1990; 60: 387–396
   PubMed Web of Science ®Google Scholar
• Buchovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• Chen P.-L., Scully P., Shew J.-Y., Wang J. Y. J., Lee W.-H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58: 1193–8
   PubMed Web of Science ®Google Scholar
• Mihara K., Cao X.-R., Yen A., Chandler S., Driscoll B., Murphree A. L., Ang A., Fung Y. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246: 1300–3
   PubMed Web of Science ®Google Scholar
• De Caprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C.-M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085–95
   PubMed Web of Science ®Google Scholar
• Lee W.-H., Shew J.-Y., Hong F. D., Sery T. W., Donoso L. A., Young L. J., Bookstein R., Lee E. Y. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642–5
   PubMed Web of Science ®Google Scholar
• Whyte P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene: athe adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124–9
   PubMed Web of Science ®Google Scholar
• De Caprio J. A., Ludlow J. W., Figge J., Shew J.-Y., Huang C.-W., Lee W.-H., Marsilio E., Paucha E., Livingston D. M. SV40 large T antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–83
   PubMed Web of Science ®Google Scholar
• Dyson N., Howley P. M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–7
   PubMed Web of Science ®Google Scholar
• Kaelin W. G., Pallas D. G., DeCaprio J. A., Kaye F. J., Livingston D. M. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 1991; 64: 521–32
   PubMed Web of Science ®Google Scholar
• Huang S., Lee W.-H., Lee E. Y. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature 1991; 350: 160–62
   PubMed Web of Science ®Google Scholar
• Bandara L. R., La Thangue N. B. Adenovirus El a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 1991; 351: 494–497
   PubMed Web of Science ®Google Scholar
• Bandara L. R., Adamczewski J. P., Hunt T., La Thangue N. B. Cyclin A and the retinoblastoma geneproduct complex with a common transcription factor. Nature 1991; 352: 249–51
   PubMed Web of Science ®Google Scholar
• Chellappan S. P., Hiebert S., Mudryj M., Horowitz J. M., Nevins J. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65: 1053–61
   PubMed Web of Science ®Google Scholar
• Bagchi S., Weinmann R., Raychaudhuri P. The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 1991; 65: 1063–72
   PubMed Web of Science ®Google Scholar
• Chittenden T., Livingston D. M., Kaelin W. G. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 1991; 65: 1073–82
   PubMed Web of Science ®Google Scholar
• Robbins P. D., Horowitz J. M., Mulligan R. C. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 1990; 346: 668–71
   PubMed Web of Science ®Google Scholar
• Moses H. L., Yang E. Y., Pietenpol J. A. TGF-stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990; 63: 245–7
   PubMed Web of Science ®Google Scholar
• Rustgi A. K., Dyson N., Bernards R. Amino terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 1991; 352: 541–4
   PubMed Web of Science ®Google Scholar
• Wagner S., Green M. R. A transcriptional tryst. Nature 1991; 352: 189–90
   PubMed Web of Science ®Google Scholar
• Weischselbaum R., Beckett M., Diamond A. Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc. Natl. Acad. Set. USA 1988; 85: 2106–9
   PubMed Web of Science ®Google Scholar
• Reissman P. T., Simon M. A., Lee W.-H., Slamon D. J. Studies of the retinoblastoma gene in human sarcomas. Oncogene 1989; 4: 839–43
   PubMed Web of Science ®Google Scholar
• Toguchida J., Ishizaki K., Sasaki M. S., Ikenaga M., Sugimoto M., Kotoura Y., Yamamuro T. Cancer Res. 1988; 48: 3939–43
   PubMed Web of Science ®Google Scholar
• Xu H.-J., Hu S.-X., Hashimoto T., Takahashi R., Benedict W. F. The retinoblastoma susceptibility gene product: A characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 1989; 4: 807–12
   PubMed Web of Science ®Google Scholar
• Yokata J., Akiyama F., Fung Y. K. T., Benedict W. F., Namba Y., Hanaoka M., Wada M., Terasaki T., Shimosato Y., Sugimura T., Terada M. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 1988; 3: 471–5
   PubMed Web of Science ®Google Scholar
• Benedict W. F., Xu H.-J., Hu S.-X., Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J. Clin. Invest. 1990; 85: 988–93
   PubMed Web of Science ®Google Scholar
• Harbour J. W., Li S., Peng J., Gazdar A. F., Minna J. D., Kaye F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–7
   PubMed Web of Science ®Google Scholar
• Lee E. Y., To H., Shew J. Y., Bookstein R., Scully P., Lee W. H. Inactivation of the retinoblastoma gene in human breast carcinoma. Science 1988; 241: 218–21
   PubMed Web of Science ®Google Scholar
• Varley J. M., Armour J., Swallow J. E., Jeffreys A. J., Ponder B. A. J., Ang A., Fung Y., Brammar W. J., Walker R. A. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 1989; 4: 725–9
   PubMed Web of Science ®Google Scholar
• Horowitz J. M., Yandell D. W., Park S.-H., Canning S., Whyte P., Buchovich K. J., Harlow E., Weinberg R. A., Dryja T. P. Point mutational inactivation of the retinoblastoma antioncogene. Science 1989; 243: 937–40
   PubMed Web of Science ®Google Scholar
• Coppola J. A., Lewis B. A., Cole M. D. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 1990; 5: 1731–3
   PubMed Web of Science ®Google Scholar
• Yen A., Chandler S., Sturzenegger-Varvayanis S. Regulated expression of the RB “tumor suppressor gene” in normal lymphocyte mitogenesis: Elevated expression in transformed leukocytes and role as a “status quo” gene. Exp. Cell Res. 1991; 192: 289–97
   PubMed Web of Science ®Google Scholar
• Furukawa Y., DeCaprio J. A., Freedman A., Kanakura Y., Nakamura M., Ernst T. J., Livingston D. M., Griffin J. D. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA 1990; 87: 2770–4
   PubMed Web of Science ®Google Scholar
• Johnson D. D., Dewald G. W., Pierre R. V., Letendre L., Silverstein M. N. Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genet. Cytogenet. 1985; 18: 235–41
   PubMed Web of Science ®Google Scholar
• Juliusson G., Osgier D. G., Fitchett M., Ross F. M., Stockdill G., Mackie M. J., Parker A. C., Castoldi G. L., Cuneo A., Knuutila S., Elonen E., Gahrton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New Engl. J. Med. 1990; 323: 720–4
   PubMed Web of Science ®Google Scholar
• Chen Y., Chen P.-J., Yeh S.-H., Tien H.-F., Wang C.-H., Tang J.-L., Hong R.-L. Deletion of the human retinoblastoma gene in primary leukemias. Blood 1990; 76: 2060–64
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. Blood 1991; 4: 833–840
   Google Scholar
• Cheng J., Scully P., Shew J.-Y., Lee W.-H., Vila V., Haas M. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 1990; 75: 730–35
   PubMed Web of Science ®Google Scholar
• Haber M. M., Inghirami G., Dalla-Favera R., Knowles D. Retinoblastoma (RB) gene product expression on B cell non-Hodgkin's lymphomas (NHLs) and lymphoid leukemias (LLs). Lab. Invest. 1991; 64: 73A
   Web of Science ®Google Scholar
• Furukawa Y., Ishida Y., Belvin M., DeCaprio J. A., Griffin J. D. Abnormalities in expression of the product of the retinoblastoma susceptibility gene in primary human leukemias. Blood 1990; 76(suppl. 1), (abstract)
   Google Scholar
• Gaidano G., Ballerni P., Cong J. Z., Inghirami G., et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar